HCC appoints Nakul Pasricha as Independent Director for five years
Hindustan Construction Company Ltd appointed Nakul Pasricha as an Independent Director for a five-year term effective July 10, 2026, following approval at its 100th AGM on August 18, 2026. The resolution passed with 99.81% shareholder support, contrasting with significant institutional dissent on financial statement adoption and chairman remuneration. Pasricha, MD & CEO of PharmaSecure, brings extensive experience in technology and anti-counterfeiting solutions to the board.

*this image is generated using AI for illustrative purposes only.
Hindustan Construction Company appointed Nakul Pasricha as an Independent Director for a term of five consecutive years, effective July 10, 2026. The appointment was ratified by shareholders at the company’s 100th Annual General Meeting (AGM) held on August 18, 2026, passing with overwhelming support.
Mr. Pasricha, who was initially appointed by the Board of Directors as an Additional Non-Executive Independent Director on July 10, 2026, is not liable to retire by rotation. The company confirmed that he is not debarred from holding office by any SEBI order or other authority. His appointment brings significant technology and anti-counterfeiting expertise to the infrastructure firm’s board.
Voting Outcomes
The AGM, conducted via Video Conferencing and Other Audio-Visual Means (OAVM), saw all resolutions pass with the requisite majority. Mr. B. Narasimhan of B N & Associates served as the Scrutinizer. Remote e-voting was managed by National Securities Depositories Limited (NSDL) between August 14 and August 17, 2026, with a cut-off date of August 11, 2026.
| Resolution | Total Votes Polled | Votes in Favour | Votes Against | % in Favour | Status |
|---|---|---|---|---|---|
| Adoption of Financial Statements (FY26) | 770,277,853 | 581,164,723 | 189,113,130 | 75.45% | Passed |
| Re-appointment of Aditya Pratap Jain | 770,277,815 | 613,534,981 | 156,742,834 | 79.65% | Passed |
| Appointment of Nakul Pasricha (Ind. Dir.) | 770,277,715 | 768,801,724 | 1,475,991 | 99.81% | Passed |
| Remuneration of Ajit Gulabchand | 770,134,777 | 583,775,224 | 186,359,553 | 75.80% | Passed |
| Ratification of Cost Auditors | 770,277,715 | 768,876,142 | 1,401,573 | 99.82% | Passed |
| Increase in Authorised Share Capital | 770,275,495 | 768,294,062 | 1,981,433 | 99.74% | Passed |
| Issue of Securities | 770,249,295 | 767,083,479 | 3,165,816 | 99.59% | Passed |
Key Observations
Promoter Support: The promoter group, holding 423,636,122 shares, voted 100% in favour of all seven resolutions. This decisive backing ensured the passage of every agenda item despite opposition from other shareholder categories.
Institutional Dissent: Public institutional investors, who polled 219,725,051 votes (62.61% of their holdings), showed significant resistance on two fronts:
- Financial Statements: 85.20% of institutional votes were cast against the adoption of the audited standalone and consolidated financial statements for FY26.
- Chairman’s Remuneration: 84.17% of institutional votes opposed the payment of remuneration to Non-Executive Chairman Ajit Gulabchand.
Conversely, these same institutions voted unanimously (100%) in favour of the appointment of Independent Director Nakul Pasricha and the ratification of cost auditors.
Public Non-Institutional Investors: This category, representing the largest shareholding base (1,844,904,998 shares), demonstrated high approval rates, voting in favour of over 98% of resolutions across the board.
Profile of New Director
Nakul Pasricha brings over 27 years of experience spanning multiple geographies and industries. He currently serves as Managing Director and CEO of PharmaSecure, a provider of technology-enabled anti-counterfeiting solutions. Under his leadership, PharmaSecure has protected more than 10 billion packs in India and Africa.
Mr. Pasricha also serves on the National Intellectual Property Rights Committee of the Confederation for Indian Industry (CII) and has been President of the Authentication Solution Providers’ Association (ASPA). He is Co-Promoter and Director of Flexing It, a platform for independent consultants. Previously, he served as Chief Information Officer for General Electric’s consumer finance division in India and started his career at Citibank in the US.
Historical Stock Returns for Hindustan Construction Company
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.67% | -1.39% | -5.60% | +44.72% | -12.11% | +172.56% |
How might the integration of Nakul Pasricha's anti-counterfeiting expertise influence HCC's digital transformation strategies or supply chain security protocols?
What specific measures will HCC implement to address the significant institutional dissent regarding the FY26 financial statements and Chairman's remuneration?
Could the 99.81% approval for Pasricha's appointment signal a broader shareholder push for enhanced corporate governance and transparency at HCC?


































